Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations (Q59793953)
Jump to navigation
Jump to search
scholarly article by Fatima Karzai et al published 4 December 2018 in Journal for Immunotherapy of Cancer
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations |
scholarly article by Fatima Karzai et al published 4 December 2018 in Journal for Immunotherapy of Cancer |
Statements
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations (English)
0 references
4 December 2018
0 references
6
0 references
1
0 references
141
0 references
1 December 2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference